<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35248142</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1824-7288</ISSN><JournalIssue CitedMedium="Internet"><Volume>48</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>05</Day></PubDate></JournalIssue><Title>Italian journal of pediatrics</Title><ISOAbbreviation>Ital J Pediatr</ISOAbbreviation></Journal><ArticleTitle>Manifesto of the pediatricians of Emilia-Romagna region, Italy, in favor of vaccination against COVID in children 5-11&#xa0;years old.</ArticleTitle><Pagination><StartPage>40</StartPage><MedlinePgn>40</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">40</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13052-022-01229-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Following the authorization by the regulatory authorities of vaccination against COVID for children aged between 5 and 11, in Emilia-Romagna Region, Italy, the pediatricians of the Italian Society of Pediatrics (SIP), the Italian Society of Neonatology (SIN), the Cultural Association of Pediatrics, the Italian Federation of Pediatricians (FIMP) and the Italian Union of Family Pediatricians (SIMPeF), who work in the hospital and in the territorial setting, have made a univocal and convinced appeal in favor of vaccination also in this age group.</AbstractText><AbstractText Label="MAIN FINDINGS" NlmCategory="RESULTS">In order to contribute to a conscious choice, on the part of parents, based on exhaustive and correct information, a 24-point manifesto was developed. The manifesto showed that vaccines against COVID are the most effective and safest tool we have to counter the spread of SARS-CoV-2 and vaccination against COVID is a right of children just as it is for adults. Children between 5 and 11&#xa0;years are not protected from the virus and a large part of the newly infected is this age. Although SARS-CoV-2 infection is certainly more benign in children, in some cases it can cause a serious pathology and long COVID. The stress caused by the pandemic, the prolonged closure of schools and the interruption of sports and recreational activities have had a devastating effect on the mental health of children and on the development of their personality. Vaccinating children against COVID serves to protect them from severe forms of disease and long COVID, allowing them to attend school face-to-face and lead a normal social life. The safety of vaccinatin is very high and vaccines against COVID have no influence on fertility nor can they cause developmental or growth side effects.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The manifesto highlighted that the vaccine against COVID for children aged between 5 and 11 is effective and safe and represents an extraordinary gift for safeguarding health of the younger ones. The invitation, therefore, to parents is to have their children vaccinated against COVID as early as possible.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Esposito</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-4103-2837</Identifier><AffiliationInfo><Affiliation>Pediatric Clinic, Pietro Barilla Children's Hospital, University of Parma, Via Gramsci 14, 43126, Parma, Italy. susanna.esposito@unimi.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Pediatricians of Emilia-Romagna Region, Italy</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ital J Pediatr</MedlineTA><NlmUniqueID>101510759</NlmUniqueID><ISSNLinking>1720-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072143" MajorTopicYN="N">Pediatricians</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccines</Keyword><Keyword MajorTopicYN="N">Caccine hesitancy</Keyword><Keyword MajorTopicYN="N">Children</Keyword><Keyword MajorTopicYN="N">Paediatric infectious diseases</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>6</Day><Hour>20</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35248142</ArticleId><ArticleId IdType="pmc">PMC8898060</ArticleId><ArticleId IdType="doi">10.1186/s13052-022-01229-2</ArticleId><ArticleId IdType="pii">10.1186/s13052-022-01229-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Food and Drug Administration. FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergen-cy Use in Children 5 through 11 Years of Age. Available at: https://www.fda.gov/news-events/press-announcements/fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use-children-5-through-11-years-age. Accessed on November 29, 2021.</Citation></Reference><Reference><Citation>European Medicines Agency. Comirnaty COVID-19 vaccine: EMA recommends approval for children aged 5 to 11. Available at: https://www.ema.europa.eu/en/news/comirnaty-covid-19-vaccine-ema-recommends-approval-children-aged-5-11. Accessed on November 29, 2021.</Citation></Reference><Reference><Citation>Principi N, Esposito S. Why it is important to develop an effective and safe pediatric COVID-19 vaccine. Vaccines (Basel) 2021;9:127. doi: 10.3390/vaccines9020127.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020127</ArticleId><ArticleId IdType="pmc">PMC7914736</ArticleId><ArticleId IdType="pubmed">33562619</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Marchetti F, Lanari M, Caramelli F, De Fanti A, Vergine G, et al. COVID-19 manage-ment in the pediatric age: consensus document of the COVID-19 working group in paediatrics of the Emilia-Romagna region (RE-CO-Ped), Italy. Int J Environ Res Public Health. 2021;18:3919. doi: 10.3390/ijerph18083919.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18083919</ArticleId><ArticleId IdType="pmc">PMC8068343</ArticleId><ArticleId IdType="pubmed">33917940</ArticleId></ArticleIdList></Reference><Reference><Citation>Principi N, Esposito S. Reasons in favour of universal vaccination campaign against COVID-19 in the pediatric population. Ital J Pediatr. 2022;48:4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8743738</ArticleId><ArticleId IdType="pubmed">35012590</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N. Multisystem inflammatory syndrome in children related to SARS-CoV-2. Paediatr Drugs. 2021;23:119&#x2013;129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819738</ArticleId><ArticleId IdType="pubmed">33479801</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Caramelli F, Principi N. What are the risk factors for admission to the pediatric inten-sive unit among pediatric patients with COVID-19? Ital J Pediatr. 2021;47:103. doi: 10.1186/s13052-021-01057-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01057-w</ArticleId><ArticleId IdType="pmc">PMC8090919</ArticleId><ArticleId IdType="pubmed">33941228</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashkenazi-Hoffnung L, Shmueli E, Ehrlich S, Ziv A, Bar-On O, Birk E, et al. Long COVID in chil-dren: observations from a designated pediatric clinic. Pediatr Infect Dis J. 2021;40:e509&#x2013;e511. doi: 10.1097/INF.0000000000003285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003285</ArticleId><ArticleId IdType="pmc">PMC8575093</ArticleId><ArticleId IdType="pubmed">34371507</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva M, et al. Risk fac-tors for long covid in previously hospitalised children using the ISARIC Global follow-up proto-col: a prospective cohort study. Eur Respir J. 2021. Epub Jul 1:2101341. 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, et al. Studying the post-COVID-19 condition: research challenges, strategies, and importance of core outcome set development. BMC Med. 2022;20:50. doi: 10.1186/s12916-021-02222-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, Di Guida D, Sigfrid L, Pizzuto DA, Di Sante G, De Rose C, et al. Evidence of lung perfusion defects and ongoing inflammation in an adolescent with post-acute sequelae of SARS-CoV-2 infection. Lancet Child Adolesc Health. 2021;5:677&#x2013;680. doi: 10.1016/S2352-4642(21)00196-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00196-6</ArticleId><ArticleId IdType="pmc">PMC8324416</ArticleId><ArticleId IdType="pubmed">34339624</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Giannitto N, Squarcia A, Neglia C, Argentiero A, Minichetti P, et al. Development of Psychological Problems Among Adolescents During School Closures Because of the COVID-19 Lockdown Phase in Italy: A Cross-Sectional Survey. Front Pediatr. 2021;8:628072. doi: 10.3389/fped.2020.628072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.628072</ArticleId><ArticleId IdType="pmc">PMC7862750</ArticleId><ArticleId IdType="pubmed">33553079</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Principi N. School closure during the coronavirus disease 2019 (COVID-19) pande-mic: an effective intervention at the global level? JAMA Pediatr. 2020;174:921&#x2013;922. doi: 10.1001/jamapediatrics.2020.1892.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2020.1892</ArticleId><ArticleId IdType="pubmed">32401277</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter EB, Talaat KR, Sabharwal C, Gurtman A, Lockhart S, Paulsen GC, Barnett ED, Mu&#xf1;oz FM, Maldonado Y, Pahud BA, et al. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age. N Engl J Med. 2021;NEJMoa2116298. 10.1056/NEJMoa2116298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8609605</ArticleId><ArticleId IdType="pubmed">34752019</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas SJ, Moreira ED, Jr, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, P&#xe9;rez Marc G, Polack FP, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 Months. N Engl J Med. 2021;385:1761&#x2013;1773. doi: 10.1056/NEJMoa2110345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2110345</ArticleId><ArticleId IdType="pmc">PMC8461570</ArticleId><ArticleId IdType="pubmed">34525277</ArticleId></ArticleIdList></Reference><Reference><Citation>Dionne A, Sperotto F, Chamberlain S, Baker AL, Powell AJ, Prakash A, Castellanos DA, Saleeb SF, de Ferranti SD, Newburger JW, Friedman KG. Association of myocarditis with BNT162b2 mes-senger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021;6(12):1446&#x2013;1450. doi: 10.1001/jamacardio.2021.3471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.3471</ArticleId><ArticleId IdType="pmc">PMC8356143</ArticleId><ArticleId IdType="pubmed">34374740</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Cotugno N, Principi N. Comprehensive and safe school strategy during COVID-19 pandemic. Ital J Pediatr. 2021;47:6. doi: 10.1186/s13052-021-00960-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-00960-6</ArticleId><ArticleId IdType="pmc">PMC7794615</ArticleId><ArticleId IdType="pubmed">33422089</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel GB, Chhiba KD, Chen MM, Guo A, Watts MM, Cullen J, Bochner BS, Grammer LC, Green-berger PA, Saltoun CA, et al. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol. Allergy Asthma Proc. 2021;42:515&#x2013;521. doi: 10.2500/aap.2021.42.210075.</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2021.42.210075</ArticleId><ArticleId IdType="pmc">PMC8654380</ArticleId><ArticleId IdType="pubmed">34871159</ArticleId></ArticleIdList></Reference><Reference><Citation>Zona S, Partesotti S, Bergomi A, Rosafio C, Antodaro F, Esposito S. Anti-COVID vaccination for adolescents: a survey on determinants of vaccine parental hesitancy. Vaccines (Basel) 2021;9:1309. doi: 10.3390/vaccines9111309.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111309</ArticleId><ArticleId IdType="pmc">PMC8618373</ArticleId><ArticleId IdType="pubmed">34835239</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Zhu S, Dai Z, Hao L, Luan C, Guo Q, Meng C, Zhang Y. Effects of COVID-19 and mRNA vaccines on human fertility. Hum Reprod. 2021. Epub Nov 3:deab238. 10.1093/humrep/deab238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689912</ArticleId><ArticleId IdType="pubmed">34734259</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministero della Salute. Intervallo temporale tra la somministrazione dei vaccini anti-SARS-CoV-2/COVID-19 e altri vaccini. Available at: http://www.quotidianosanita.it/allegati/allegato3558124.pdf Accessed on December 14, 2021.</Citation></Reference><Reference><Citation>Liu Y, Rockl&#xf6;v J. The reproductive number of the delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 Virus. J Travel Med. 2021;28:taab124. doi: 10.1093/jtm/taab124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jtm/taab124</ArticleId><ArticleId IdType="pmc">PMC8436367</ArticleId><ArticleId IdType="pubmed">34369565</ArticleId></ArticleIdList></Reference><Reference><Citation>AIFA. FAQ &#x2013; Vaccino COVID-19. Available at: https://www.aifa.gov.it/domande-e-risposte-su-vaccini-covid-19 Accessed on Dececember 14, 2021.</Citation></Reference><Reference><Citation>Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, Mandelboim M, Levin EG, Rubin C, Indenbaum V, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385:1474&#x2013;1484. doi: 10.1056/NEJMoa2109072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109072</ArticleId><ArticleId IdType="pmc">PMC8362591</ArticleId><ArticleId IdType="pubmed">34320281</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Wang M, Zhang X, Liu T, Libby P, Shi GP. COVID-19, the pandemic of the century and its impact on cardiovascular diseases. Cardiol Discov. 2021;1:233&#x2013;258. doi: 10.1097/CD9.0000000000000038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CD9.0000000000000038</ArticleId><ArticleId IdType="pmc">PMC8638821</ArticleId><ArticleId IdType="pubmed">34888547</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkrief A, Wu JT, Jani C, Enriquez KT, Glover M, Shah MR, Shaikh HG, Beeghly-Fadiel A, French B, Jhawar SR, et al. Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer. Cancer Discov. 2021; Epub Dec 10:candisc.1368.2021. doi: 10.1158/2159-8290.CD-21-1368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831477</ArticleId><ArticleId IdType="pubmed">34893494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>